Surgery Websites
LiverSource »  Faculty »  Hepatology »  Monika Sarkar, M.D., MAS
Monika Sarkar, M.D., MAS

Monika Sarkar, M.D., MAS

  • Associate Professor 
  • Department of Medicine
  • Division of Gastroenterology and Hepatology

Contact Information

Academic Office
Division of Gastroenterology
513 Parnassus Avenue, Room S-357
San Francisco, CA 94143-0358
(415) 476-6422 - Phone
(415) 476-0659 - Fax
Open Popup

Vassar College, BA, French & Biology, 1998-2002

University of California, San Francisco School of Medicine, MD, 2002-2006

  • Hospital of the University of Pennsylvania, Intern, Internal Medicine, 2006-2007
  • Hospital of the University of Pennsylvania, Resident, Internal Medicine, 2007-2009
  • University of California, San Francisco, Fellow, Gastroenterology, 2009-2012
  • University of California, San Francisco, Fellow, Transplant Hepatology, 2012-2013
  • University of California, San Francisco, Masters in Clinical Research, 2011-2012
  • American Board of Internal Medicine
  • American Board of Internal Medicine - Gastroenterology
  • American Board of Internal Medicine - Transplant Hepatology
  • UCSF Liver Center
  • Gender differences in liver transplant outcomes
  • Non invasive measures of liver fibrosis
  • Women with chronic liver disease
  • Spanish

Dr. Monika Sarkar is a transplant hepatologist and focuses on viral hepatitis and non-alcoholic fatty liver disease, as well as liver disease in pregnancy. She has a particular research interest in women's health, including the role of sex hormones in the progression of liver disease. Dr. Sarkar supervises the training of medicine residents and both gastroenterology and liver transplant fellows. She earned her medical degree at the University of California, San Francisco and completed internal medicine residency at the University of Pennsylvania. She then completed fellowships in gastroenterology and transplant hepatology, as well as her Masters in Clinical Research at UCSF.

  Award  
  Confired By    
  Date    
  • R03
  • NIDDK
  • 2022 - 2024
  • K23
  • NIDDK
  • 2017 - 2023
  • K23
  • NIDDK
  • 2017 - 2022
  • K Scholars Team Science Award
  • UCSF
  • 2017 - 2018
  • UCSF Hellman Research Award
  • UCSF
  • 2016 - 2018
  • RAP Pilot Award for Junior Investigators
  • UCSF
  • 2016 - 2017
  • Liver Center Flex Funds
  • UCSF
  • 2015 - 2016
  • Liver Center Pilot/Feasibility Research Award
  • UCSF Liver Center
  • 2014 - 2015
  • Sheila Sherlock Career Development Research Award
  • AASLD
  • 2013 - 2015
  • Advanced Hepatology Fellowship Award
  • AASLD
  • 2012 - 2013
  • My research program is focused on the role of sex hormones on liver injury in women, including the effects of reproductive aging, pregnancy, and androgens. I have a specific interest in young women with the hyperandrogenic condition known as Polycystic Ovarian Syndrome as these women are at high risk for developing Non Alcoholic Fatty Liver Disease and early onset liver scarring. Within the transplant setting I also study sex differences in waitlist and post transplant outcomes.

    Data provided by UCSF Profiles, powered by CTSI
    ORCID iD: 0000-0003-4233-1062 Additional info
    • Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
      Sponsor:
      Sponsor ID:
      Funding Period:
      Mar 2022
      -
      Mar 2024
      Principle Investigator
    • Androgens and Nonalcoholic Steatohepatitis: The Role of Male Sex Hormones in Women with NASH
      Sponsor:
      Sponsor ID:
      Funding Period:
      Jul 2017
      -
      Jun 2022
      Principal Investigator
    Data provided by UCSF Profiles, powered by CTSI
    MOST RECENT PUBLICATIONS FROM A TOTAL OF 84
    Data provided by UCSF Profiles, powered by CTSI
    1. Katherine M. Cooper, Molly Delk, Deepika Devuni, Monika Sarkar. Sex Differences in Chronic Liver Disease and Benign Liver Lesions. JHEP Reports. 2023 Aug 1; 100870. View in PubMed
    2. Meera Garriga, Marcelle I. Cedars, Monika Sarkar. Mo1530 OUTCOMES IN WOMEN WITH CHRONIC LIVER DISEASE UNDERGOING INFERTILITY TREATMENT. Gastroenterology. 2023 May 1; 164(6):s-1365. View in PubMed
    3. Patel-Sanchez N, Perito E, Tsai P, Raymond-Flesch M, Lodish M, Sarkar M. Prevalence of nonalcoholic fatty liver disease increased with type 2 diabetes mellitus in overweight/obese youth with polycystic ovary syndrome. J Pediatr Endocrinol Metab. 2023 May 25; 36(5):441-446. View in PubMed
    4. Levy C, Brady CW, Terrault N, Stotts MJ, Sarkar M. Reproductive health and liver disease: a patient-friendly summary of the 2021 AASLD guidance. Clin Liver Dis (Hoboken). 2023 Jan; 21(1):19-35. View in PubMed
    5. Sarkar M, Flemming JA. Letter to the Editor: Influence of maternal NAFLD on infant weight-the real precursor to NAFLD in offspring? Hepatology. 2023 06 01; 77(6):E180. View in PubMed
    6. View All Publications

     

    Site Directory
      X